Estrogen also amplifies mTOR outputs via IGF-1R upregulation, sustaining proliferative/survival programs that are accentuated in obesity-related endocrine milieus (increased aromatization, reduced SHBG) [37,45]. The gene discussed is MTOR; the disease is obesity disorder.